Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Judge 

UnitedHealth Group Inc. diskutieren

UnitedHealth Group Inc.

WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Aktie / Anbieter & Dienstleistungen / Large Cap /

291,20 €
1,59 %

Einschätzung Buy
Rendite (%) 29,31 %
Kursziel 302,58
Veränderung
Endet am 30.07.26

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at KeyCorp from $400.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 29,14 %
Kursziel 247,25
Veränderung
Endet am 30.07.26

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Royal Bank Of Canada from $355.00 to $286.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Sell
Rendite (%) 27,19 %
Kursziel 173,21
Veränderung
Endet am 31.07.26

UnitedHealth Group Incorporated (NYSE: UNH) had its "underperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $198.00 price target on the stock, down previously from $312.00.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 40,17 %
Kursziel 230,66
Veränderung
Endet am 04.08.26

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Wells Fargo & Company from $306.00 to $267.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 13,44 %
Kursziel 279,44
Veränderung
Endet am 20.08.26

UnitedHealth Group (NYSE:UNH) had its price target lowered by analysts at Morgan Stanley from $342.00 to $325.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,76 %
Kursziel 377,96
Veränderung
Endet am 26.08.26

UnitedHealth Group (NYSE:UNH) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $440.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,05 %
Kursziel 301,84
Veränderung
Endet am 04.09.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Barclays PLC from $337.00 to $352.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,76 %
Kursziel 324,92
Veränderung
Endet am 05.09.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Sanford C. Bernstein from $337.00 to $379.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,57 %
Kursziel 310,03
Veränderung
Endet am 09.09.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Truist Financial Corporation from $310.00 to $365.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,07 %
Kursziel 336,78
Veränderung
Endet am 12.09.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Morgan Stanley from $325.00 to $395.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,45 %
Kursziel 341,92
Veränderung
Endet am 07.10.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Wells Fargo & Company from $267.00 to $400.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,99 %
Kursziel 344,04
Veränderung
Endet am 08.10.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at KeyCorp from $350.00 to $400.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -8,87 %
Kursziel 372,42
Veränderung
Endet am 08.10.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Sanford C. Bernstein from $379.00 to $433.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,28 %
Kursziel 331,61
Veränderung
Endet am 09.10.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Barclays PLC from $352.00 to $386.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,21 %
Kursziel 369,41
Veränderung
Endet am 09.10.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Mizuho from $300.00 to $430.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,10 %
Kursziel 365,12
Veränderung
Endet am 09.10.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at JPMorgan Chase & Co. from $310.00 to $425.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,27 %
Kursziel 350,87
Veränderung
Endet am 14.10.26

UnitedHealth Group (NYSE:UNH) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $406.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,84 %
Kursziel 349,49
Veränderung
Endet am 17.10.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Jefferies Financial Group Inc. from $317.00 to $409.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -7,91 %
Kursziel 357,70
Veränderung
Endet am 28.10.26

UnitedHealth Group (NYSE:UNH) was given a new $417.00 price target on by analysts at Piper Sandler. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,07 %
Kursziel 350,27
Veränderung
Endet am 29.10.26

UnitedHealth Group (NYSE:UNH) had its price target raised by analysts at Royal Bank Of Canada from $286.00 to $408.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat